Showing results (131-140 of 501) with videos related to
Sort By:
Pageof 51
BMJ Neurology Open|May 23, 2022
Methanol-induced parkinsonism and cerebral vasculopathy due to perfume inhalationWalaa B Mohammed, Salma Tarabzouni, Saeed BohlegaBMJ Neurology Open|November 12, 2021
Autoimmune glial fibrillary acidic protein astrocytopathy presented as ataxia, myoclonus and bulbar syndrome: a case report and review of the literatureAzael C Novo, Begoña Venegas PérezBMJ Neurology Open|March 8, 2021
Progressive cranial neuropathy and uterine involvement in myeloid sarcomaAnthony Khoo, Thomas Kimber, Penelope Cohen, et al.BMJ Neurology Open|March 8, 2021
Recurrent transient heading disorientation heralding acute posterior cerebral artery (PCA) infarctionYong Chuan Chee, Beng Hooi OngBMJ Neurology Open|March 8, 2021
Novel RNASEH2C mutation in multiple members of a large family: insights into phenotypic spectrum of Aicardi-Goutières SyndromeDema Lhamtsho, Uddandam Rajesh, Apoorv Saxena, et al.BMJ Neurology Open|March 8, 2021
Effect of remote ischaemic preconditioning on walking in people with multiple sclerosis: double-blind randomised controlled trialChayaporn Chotiyarnwong, Krishnan Nair, Lorenza Angelini, et al.BMJ Neurology Open|March 8, 2021
Case report and literature review of Huntington disease with intermediate CAG expansionStefan D Jevtic, John P ProviasBMJ Neurology Open|March 8, 2021
Hospital diagnosed pneumonia before age 20 years and multiple sclerosis riskKelsi A Smith, Ayako Hiyoshi, Sarah Burkill, et al.BMJ Neurology Open|March 8, 2021
Characteristics and treatment effectiveness of the nummular headache: a systematic review and analysis of 110 casesUrvish K Patel, Sidra Saleem, Arsalan Anwar, et al.BMJ Neurology Open|March 8, 2021
Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trialAnne C La Flamme, David Abernethy, Dalice Sim, et al.Pageof 51